GLP Watchdog

Fridays vs Gala

Neither Fridays nor Gala has an FDA warning letter on record. On brand-name semaglutide pen, Gala costs $2,388 less a year at standing rates: $1,299 a month against $1,498 a month at Fridays. It is one of three products the two sell at comparable terms.

To see where both sit among the other sellers, read our best weight-loss injection providers board.

By Ruth Calder · Enforcement Editor
Editorially reviewed. Not medical advice · How we verify contentLast reviewed

The record

Fridays / Gala

Fridays logo

Fridays

5.8/10

Featured pick (affiliate partner)

Gala logo

Gala

8.5/10

FDA warning letters
None on record
None on record
Pharmacy
None named in our record
Lowest standing price
$249/moCompounded semaglutide injection
$179/moCompounded semaglutide injection
States
No state list published
All 50 states
Checked
Prices captured Record checked October 2026
Prices captured Record checked October 2026
Visit Fridays
Visit Gala

Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (Fridays 5.8, Gala 8.5). How we are paid

What the record shows

  1. 01

    Neither Fridays nor Gala has an FDA warning letter on record.

  2. 02

    Fridays names four pharmacies. Gala names no compounding pharmacy in our record.

  3. 03

    On brand-name semaglutide pen, Gala costs $2,388 less a year at standing rates: $1,299 a month against $1,498 a month at Fridays. It is one of three products the two sell at comparable terms.

  4. 04

    Only Fridays lists a price for brand-name tirzepatide pen.

  5. 05

    Gala lists all 50 states. Fridays publishes no state list.

Prices and terms, product by product

A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.

Fridays

Gala

Compounded semaglutide injection

$249/mo

$2,988 a year

$179/moLower

$2,148 a year

Compounded tirzepatide injection

$359/mo

$4,308 a year

$179/moLower

$2,148 a year

Brand-name semaglutide pen

$1,498/mo

$17,976 a year

$1,299/moLower

$15,588 a year

Brand-name tirzepatide pen

$1,828/mo

$21,936 a year

Not sold or not priced
Price includes
Medication, clinician visits, coaching
Medication, clinician visits, shipping
Cancel any time
Yes, stated
Yes, stated
Minimum term
None on the monthly plan; 3, 6 and 12-month plans are prepaid
Yearly plan for the $179 rate; 72 hours' notice before the billing date to cancel
Refunds
Fees are non-refundable except for medical disqualification, billing errors or where the law requires
No refund on cancellation; full refund only if the medical provider disqualifies you

Read off each seller’s own pages. Fridays: October 30, 2026. Gala: October 17, 2026. Every plan and dose we hold is on the full review.

The case for each

The case for Fridays

5.8/10
  • Sells brand-name tirzepatide pen, which Gala does not price
  • Names its compounding pharmacy
  • Publishes no state list
Visit Fridays

The case for Gala

8.5/10
Featured pick (affiliate partner)
  • $840 a year less on compounded semaglutide injection
  • $2,160 a year less on compounded tirzepatide injection
  • Names no compounding pharmacy
Visit Gala

Scores

Fridays 5.8 · Gala 8.5 out of 10. Six weighted parts.

Value25%

3.4A
vs
B
7.9

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

3.0A
vs
B
8.0

Trust & Safety15%

5.5A
vs
B
7.5

Accessibility10%

5.0A
vs
B
10.0

Support10%

7.0A
vs
B
7.0

The score is the same formula for every seller. Payment does not enter it. Method

Fridays vs Gala: questions

Neither Fridays nor Gala has an FDA warning letter on record. Letters are matched to a seller by company, domain and address, never by a similar name.
Fridays names four pharmacies. Gala names no compounding pharmacy in our record. A 503A pharmacy compounds for named patients on a prescription; a 503B outsourcing facility is registered with FDA and inspected under federal manufacturing rules.
Gala, by $840 a year at standing rates. Fridays: $249 a month, about $2,988 a year. Gala: $179 a month, about $2,148 a year.
Fridays states you can cancel at any time; refunds: fees are non-refundable except for medical disqualification, billing errors or where the law requires. Gala states you can cancel at any time; refunds: no refund on cancellation; full refund only if the medical provider disqualifies you.
Gala is our featured pick on this page because it is an affiliate partner: we are paid if you sign up through our link. Fridays pays us nothing. The scores are computed the same way for both and are shown as computed (Fridays 5.8, Gala 8.5).

Other sellers we are paid by

Affiliate partners outside this pair. Each has its own record and review, scored the same way.

Sellers closest to these two

Matched on molecule, form and price. Every pair we list · The register

Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks